Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration
Clinical trial NCT02944227 · COMPLETED
Trial details
- NCT number
- NCT02944227
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-03
- Primary completion
- 2017-02-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.